The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CALGB 90203 (Alliance): Radical prostatectomy (RP) with or without neoadjuvant chemohormonal therapy (CHT) in men with clinically localized, high-risk prostate cancer (CLHRPC).
 
James Andrew Eastham
No Relationships to Disclose
 
Glenn Heller
Research Funding - Janssen Diagnostics
 
Susan Halabi
Consulting or Advisory Role - Eisai; Ferring
 
Paul Monk
Consulting or Advisory Role - Lilly
Travel, Accommodations, Expenses - Lilly
 
Steven K. Clinton
Research Funding - American Cancer Society; American Institute for Cancer Research; Department of Defense-Prostate Cancer Research Program; NIH; The National Cattleman's Beef Association; United States Department of Agriculture
 
Russell Zelig Szmulewitz
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; AstraZeneca; Exelixis; Janssen Oncology; Merck; Pfizer; Sanofi
Research Funding - Abbvie; Astellas Pharma; Incyte; Janssen Oncology; Macrogenics
Patents, Royalties, Other Intellectual Property - Patent licensed by University of Chicago of which I am co-inventor to Corcept Therapeutics for combination AR/GR inhibition in prostate cancer
Travel, Accommodations, Expenses - Corcept Therapeutics
 
Jonathan Coleman
Travel, Accommodations, Expenses - Digital Angiography Reading Center (I)
Other Relationship - Steba Biotech
 
Martin Gleave
Stock and Other Ownership Interests - OncoGenex
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Genova Diagnostics; Janssen; MDxHealth; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; AstraZeneca; Bayer; Genova Diagnostics; Janssen; MDxHealth; Sanofi
Research Funding - Astellas Pharma; Bayer; Janssen
Patents, Royalties, Other Intellectual Property - OncoGenex - OGX-011, OGX-427
 
Christopher P. Evans
Stock and Other Ownership Interests - Exelixis
Honoraria - Janssen Oncology; Medivation; Sanofi
Consulting or Advisory Role - Astellas Pharma; Janssen Oncology; MDxHealth; Medivation; Sanofi
Speakers' Bureau - Astellas Pharma; Janssen Oncology; MDXHealth; Medivation; Sanofi
Research Funding - Astellas Pharma; Ferring; Medivation; Sanofi
Travel, Accommodations, Expenses - Astellas Pharma; Janssen Oncology; Sanofi
 
David W. Hillman
No Relationships to Disclose
 
Himisha Beltran
Consulting or Advisory Role - Abbvie; Astellas Pharma; Genzyme; GlaxoSmithKline; Janssen Oncology
Research Funding - Abbvie/Stemcentrx (Inst); Janssen (Inst); Lilly (Inst)
 
Mary-Ellen Taplin
Honoraria - Astellas Pharma; Bayer; Clovis Oncology; Incyte; Janssen-Ortho; Pfizer; Research to Practice; UpToDate
Consulting or Advisory Role - AstraZeneca; Bayer; Best Doctors, Inc; Clovis Oncology; Guidepoint Global; Incyte; Janssen-Ortho; Myovant Sciences; Pfizer; Research to Practice; UpToDate
Research Funding - Bayer (Inst); Janssen-Ortho (Inst); Medivation (Inst); Pfizer (Inst); Tokai Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Clovis Oncology; Incyte; Janssen Oncology; Medivation; Pfizer; Tokai Pharmaceuticals
 
Olwen Mary Hahn
Leadership - Via Oncology
Honoraria - Cardinal Health (I)
Consulting or Advisory Role - Pfizer; Pfizer
Travel, Accommodations, Expenses - Cardinal Health (I)
 
J Kellogg Parsons
Stock and Other Ownership Interests - Johnson & Johnson; Omega Healthcare Investors; Pfizer; Urigen Pharmaceuticals
Honoraria - Sophiris Bio
Other Relationship - MDxHealth
 
Eric Jay Small
Stock and Other Ownership Interests - Fortis; Harpoon Therapeutics
Honoraria - Janssen
Consulting or Advisory Role - Fortis; Janssen Oncology
Research Funding - Janssen (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Janssen
 
James Mohler
No Relationships to Disclose
 
Michael J. Morris
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; Bayer; Blue Earth Diagnostics; Endocyte; Tokai Pharmaceuticals; Tolmar
Speakers' Bureau - ORIC Pharmaceuticals
Research Funding - Bayer (Inst); Corcept Therapeutics (Inst); Endocyte (Inst); Progenics (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bayer; Endocyte